Company: LNAI
Filing Date: 2025-11-03
Form Type: 8-K
Source: 0001731122-25-001465
Chunk: 0

Company: Lunai Bioworks Inc.
Filing Date: 2025-11-03
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item
5.07 Submission of Matters to a Vote of Security Holders.

An
annual meeting of our shareholders was held on October 31, 2025 (the “ Annual Meeting”). At the Annual Meeting, our shareholders
voted on each of the following four matters:

  To                                                                                     

  To                                                                                        

  To                                                                                       
  approve by a non-binding advisory vote the appointment of Sadler, Gibb & Associates LLC  
  (“ Sadler ”) as the Company’s independent registered public accounting                   
  firm for the fiscal year ending June 30, 2026 (the “ Auditor Ratification Proposal ”);   
  and                                                                                      
 ───────────────────────────────────────────────────────────────────────────────────────────

  To                                                                                                 
  approve proposed amendments to the Renovaro Biosciences, Inc. 2023 Equity Incentive Plan,          
  as amended, in substantially the form attached to the proxy statement as Annex A (the “ Incentive  
  Plan Proposal ”).                                                                                  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────

According
to the final vote, the Company’s stockholders approved proposals 1, 2, 3, and 4.

The
final vote results for each of these four matters is set forth below.

Proposal
1 Election E ht Directors

                               For      Withheld      Broker Non-Vote 1  
 ─────────────────────────────────────────────────────────────────────────
  David Weinstein        7,539,245       202,737                         
  James McNulty          7,368,045       373,937                         
  Douglas W. Calder      7,343,710       398,272                         
  Mark A, Collins        7,368,381       373,601                         

1

The
election of directors described above was conducted in accordance with the applicable requirements of Nasdaq Listing Rule 5605(e), which
governs the process for the election of directors and requires that a majority of the board’s members be independent directors
as defined in Nasdaq Listing Rule 5605(a)(2). The Company further confirms that the director nomination and election process complied
with all applicable Nasdaq corporate governance standards, including those relating to the composition and independence of the Nominating
and Corporate Governance Committee under Rule 5605(e)(1) and the shareholder approval and voting requirements under Rule 5620. The election
of directors at the Annual Meeting was duly conducted